blood exchange at the beginning of cardiopulmonary bypass to eliminate the circulating factor responsible and so allow the use of standard heparin during and after the operation : this is the only possible solution in cases with in vitro aggregant activity of lmwh .
C0019134
heparin
C0019139
lmwh